Correction to “Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first-line treatment within the randomized Phase III trial FIRE-3 (AIO KRK-0306)”
{"title":"Correction to “Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first-line treatment within the randomized Phase III trial FIRE-3 (AIO KRK-0306)”","authors":"","doi":"10.1002/ijc.35186","DOIUrl":null,"url":null,"abstract":"<p>\n <span>Liu, L</span>, <span>Erickson, NT</span>, <span>Ricard, I</span>, et al. <span>Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first-line treatment within the randomized Phase III trial FIRE-3 (AIO KRK-0306)</span>. <i>Int J Cancer</i>. <span>2022</span>; <span>150</span>(<span>1</span>): <span>112</span>-<span>123</span>. doi:10.1002/ijc.33775\n </p><p>Hana Algül's affiliation was provided incorrectly and should have been “Comprehensive Cancer Center München, Chair for Tumor Metabolism, Klinikum rechts der Isar, Technical University of Munich, School of Medicine and Health, Munich, Bavaria, Germany.”</p><p>We apologize for this error.</p>","PeriodicalId":180,"journal":{"name":"International Journal of Cancer","volume":"156 1","pages":"E1"},"PeriodicalIF":5.7000,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ijc.35186","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Cancer","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ijc.35186","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Liu, L, Erickson, NT, Ricard, I, et al. Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first-line treatment within the randomized Phase III trial FIRE-3 (AIO KRK-0306). Int J Cancer. 2022; 150(1): 112-123. doi:10.1002/ijc.33775
Hana Algül's affiliation was provided incorrectly and should have been “Comprehensive Cancer Center München, Chair for Tumor Metabolism, Klinikum rechts der Isar, Technical University of Munich, School of Medicine and Health, Munich, Bavaria, Germany.”
更正 "在随机 III 期试验 FIRE-3 (AIO KRK-0306) 中，早期体重减轻是接受一线治疗的转移性结直肠癌患者生存期缩短和副作用增加的独立风险因素"
Liu, L, Erickson, NT, Ricard, I, et al. 在随机 III 期试验 FIRE-3 (AIO KRK-0306) 中，早期体重减轻是导致接受一线治疗的转移性结直肠癌患者生存期缩短和副作用增加的独立风险因素。Int J Cancer. 2022; 150(1):112-123. doi:10.1002/ijc.33775 Hana Algül的工作单位有误，应为 "Comprehensive Cancer Center München, Chair for Tumor Metabolism, Klinikum rechts der Isar, Technical University of Munich, School of Medicine and Health, Munich, Bavaria, Germany. "我们对此错误深表歉意。
期刊介绍：
The International Journal of Cancer (IJC) is the official journal of the Union for International Cancer Control—UICC; it appears twice a month. IJC invites submission of manuscripts under a broad scope of topics relevant to experimental and clinical cancer research and publishes original Research Articles and Short Reports under the following categories:
-Cancer Epidemiology-
Cancer Genetics and Epigenetics-
Infectious Causes of Cancer-
Innovative Tools and Methods-
Molecular Cancer Biology-
Tumor Immunology and Microenvironment-
Tumor Markers and Signatures-
Cancer Therapy and Prevention
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
